
Elucidate Bio offers cutting-edge spatial biology services, specializing in same-tissue imaging of DNA, RNA, and proteins at single-cell resolution. Their technology, licensed from Harvard Medical School, enables high-plex spatial proteomics, transcriptomics, and genomics, coupled with advanced AI-driven analysis. This empowers pharmaceutical research by accelerating drug discovery, revealing novel biomarkers, and unlocking translational insights, ultimately reducing program timelines, improving resource efficiency, and yielding high-quality, reliable data for better drug development choices and patient stratification.

Elucidate Bio offers cutting-edge spatial biology services, specializing in same-tissue imaging of DNA, RNA, and proteins at single-cell resolution. Their technology, licensed from Harvard Medical School, enables high-plex spatial proteomics, transcriptomics, and genomics, coupled with advanced AI-driven analysis. This empowers pharmaceutical research by accelerating drug discovery, revealing novel biomarkers, and unlocking translational insights, ultimately reducing program timelines, improving resource efficiency, and yielding high-quality, reliable data for better drug development choices and patient stratification.